BC-05

CAT: 0804-HY-149514Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-149514Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research[1].
CAS Number
[2260717-73-3]
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bc-05.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CC(C)C)B1OC(C(CC(O)=O)(CC(O)=O)O1)=O)[C@@H](O)[C@H](N)CC2=CC=CC=C2
Molecular Formula
C21H29BN2O9
Molecular Weight
464.27
References & Citations
[1]Zhang J, et al. Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules. 2023 Aug 30;28 (17) :6343.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W128219-01BC-NH2
HY-P991331BC-010
HY-D2953BC-CPY
HY-119288-01BC-23
HY-161901BC-1293
HY-113640-01BC-7013
HY-W062696-01BC-1382
HY-160876-01BC-1901S
HY-D2959BC-DF
HY-114366-01BC-1485

Alternative Products

CatalogName
MBS5820508BC-05
MBS3605379-01BC-23
MBS5759350BC-1382
MBS5774875BC 197
TRC-B358215-250MGBC-1471
BUP01020-01BC-1485
BA3188-100BC-1258
MF-0093979-01BC-?1258
MF-0100824-01BC-010
MF-0100557-01BC-1293

Popular Products